Related references
Note: Only part of the references are listed.Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
Esther A. Obeng et al.
CANCER CELL (2016)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
Xiongwei Cai et al.
CELL STEM CELL (2015)
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer
Salima Daou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination
D. Inoue et al.
LEUKEMIA (2015)
Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex
Anand Balasubramani et al.
NATURE COMMUNICATIONS (2015)
Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7)
Xiaodan Ding et al.
PLOS ONE (2015)
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice
Jiapeng Wang et al.
BLOOD (2014)
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Rafael Bejar et al.
BLOOD (2014)
AP2α transcriptional activity is essential for retinoid-induced neuronal differentiation of mesenchymal stem cells
Yang Bi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Targeting histone methyltransferase EZH2 as cancer treatment
Yutaka Kondo
JOURNAL OF BIOCHEMISTRY (2014)
O-GlcNAc and the Epigenetic Regulation of Gene Expression
Brian A. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cancer Metabolism and Elevated O-GlcNAc in Oncogenic Signaling
Zhiyuan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
O-GlcNAcylation regulates EZH2 protein stability and function
Chi-Shuen Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
Goro Sashida et al.
NATURE COMMUNICATIONS (2014)
O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells
Harri M. Itkonen et al.
CANCER RESEARCH (2013)
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
Rachel Deplus et al.
EMBO JOURNAL (2013)
Ten-Eleven Translocation 1 (Tet1) Is Regulated by O-Linked N-Acetylglucosamine Transferase (Ogt) for Target Gene Repression in Mouse Embryonic Stem Cells
Feng-Tao Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mixed Lineage Leukemia 5 (MLL5) Protein Regulates Cell Cycle Progression and E2F1-responsive Gene Expression via Association with Host Cell Factor-1 (HCF-1)
Peipei Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells
Zhiyuan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations
Daichi Inoue et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Omar Abdel-Wahab et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tet Proteins Connect the O-Linked N-acetylglucosamine Transferase Ogt to Chromatin in Embryonic Stem Cells
Pietro Vella et al.
MOLECULAR CELL (2013)
TET2 promotes histone O-GlcNAcylation during gene transcription
Qiang Chen et al.
NATURE (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Veronique Gelsi-Boyer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
Anwesha Dey et al.
SCIENCE (2012)
GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression
Zhong-Fa Yang et al.
BLOOD (2011)
Clinical Implications of Novel Mutations in Epigenetic Modifiers in AML
Omar Abdel-Wahab et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Felicitas Thol et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid Leukemia
Frederik Damm et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
O-GlcNAc signalling: implications for cancer cell biology
Chad Slawson et al.
NATURE REVIEWS CANCER (2011)
Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia
Cynthia L. Fisher et al.
BLOOD (2010)
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Functional Conservation of Asxl2, a Murine Homolog for the Drosophila Enhancer of Trithorax and Polycomb Group Gene Asx
Heather A. Baskind et al.
PLOS ONE (2009)
The Organization of Histone H3 Modifications as Revealed by a Panel of Specific Monoclonal Antibodies
Hiroshi Kimura et al.
CELL STRUCTURE AND FUNCTION (2008)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia
Jd Gibbs et al.
ONCOGENE (2008)
The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation
Mark W. Feinberg et al.
EMBO JOURNAL (2007)
Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family
CL Fisher et al.
GENE (2006)
O-GlcNAc a sensor of cellular state:: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress
NE Zachara et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2004)
A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11
CL Fisher et al.
GENE (2003)
MafB is an inducer of monocytic differentiation
LM Kelly et al.
EMBO JOURNAL (2000)
The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP
JL Vogel et al.
EMBO JOURNAL (2000)
Share Paper
